{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:08:28Z","timestamp":1788944908788,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-026-01196-9","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:20:03Z","timestamp":1786011603000},"page":"747-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arterial-myocardial coupling in primary light chain amyloidosis: A prospective observational study of vascular involvement"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Patras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-0087","authenticated-orcid":false,"given":"Dimitris","family":"Delialis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Petropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Theodorakakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"1196_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00789-8","volume":"13","author":"G Palladini","year":"2023","unstructured":"Palladini G, Sch\u00f6nland S, Merlini G, Milani P, Jaccard A, Bridoux F, et al. The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood Cancer J. 2023;13:19.","journal-title":"Blood Cancer J"},{"key":"1196_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/hon.3135","volume":"41","author":"F Theodorakakou","year":"2023","unstructured":"Theodorakakou F, Briasoulis A, Fotiou D, Petropoulos I, Georgiopoulos G, Lama N, et al. Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease. Hematol Oncol. 2023;41:725\u201332.","journal-title":"Hematol Oncol"},{"key":"1196_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/10428194.2023.2197537","volume":"64","author":"D Fotiou","year":"2023","unstructured":"Fotiou D, Theodorakakou F, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kanellias N, et al. Patterns of target organ amyloid deposition in patients with AL amyloidosis; role for diagnosis and prognosis. Leuk Lymphoma. 2023;64:1212\u20135.","journal-title":"Leuk Lymphoma"},{"key":"1196_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/CIRCRESAHA.119.314862","volume":"125","author":"K Stamatelopoulos","year":"2019","unstructured":"Stamatelopoulos K, Georgiopoulos G, Athanasouli F, Nikolaou PE, Lykka M, Roussou M, et al. Reactive vasodilation predicts mortality in primary systemic light-chain amyloidosis. Circ Res. 2019;125:744\u201358.","journal-title":"Circ Res"},{"key":"1196_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/heart.88.6.615","volume":"88","author":"L Bernardi","year":"2002","unstructured":"Bernardi L, Passino C, Porta C, Anesi E, Palladini G, Merlini G. Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension? Heart. 2002;88:615\u201321.","journal-title":"Heart"},{"key":"1196_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/eurheartj\/ehm066","volume":"28","author":"KM Modesto","year":"2007","unstructured":"Modesto KM, Dispenzieri A, Gertz M, Cauduro SA, Khandheria BK, Seward JB, et al. Vascular abnormalities in primary amyloidosis. Eur Heart J. 2007;28:1019\u201324.","journal-title":"Eur Heart J"},{"key":"1196_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/ana.10552","volume":"53","author":"M Berghoff","year":"2003","unstructured":"Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol. 2003;53:725\u201330.","journal-title":"Ann Neurol"},{"key":"1196_CR8","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1161\/01.CIR.102.22.2707","volume":"102","author":"DM Kaye","year":"2000","unstructured":"Kaye DM, Ahlers BA, Autelitano DJ, Chin-Dusting JP. In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation. 2000;102:2707\u201312.","journal-title":"Circulation"},{"key":"1196_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ehjci\/jead351","volume":"25","author":"A Briasoulis","year":"2023","unstructured":"Briasoulis A, Bampatsias D, Petropoulos I, Rempakos A, Patras R, Theodorakakou F, et al. Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light-chain cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2023;25:698\u2013707.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1196_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"LP Badano","year":"2018","unstructured":"Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19:591\u2013600.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1196_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13244-022-01194-8","volume":"13","author":"N Lama","year":"2022","unstructured":"Lama N, Briasoulis A, Karavasilis E, Stamatelopoulos K, Chasouraki A, Alexopoulou E, et al. The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis. Insights Imaging. 2022;13:55.","journal-title":"Insights Imaging"},{"key":"1196_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101573","volume":"48","author":"A Briasoulis","year":"2023","unstructured":"Briasoulis A, Lama N, Rempakos A, Theodorakakou F, Stamatelopoulos K, Dimopoulos MA, et al. Diagnostic and prognostic value of non-late gadolinium enhancement cardiac magnetic resonance parameters in cardiac amyloidosis. Curr Probl Cardiol. 2023;48:101573.","journal-title":"Curr Probl Cardiol"},{"key":"1196_CR13","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.4065\/83.11.1226","volume":"83","author":"AK Wang","year":"2008","unstructured":"Wang AK, Fealey RD, Gehrking TL, Low PA. Patterns of neuropathy and autonomic failure in patients with amyloidosis. Mayo Clin Proc. 2008;83:1226\u201330.","journal-title":"Mayo Clin Proc"},{"key":"1196_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/0002-8703(93)90756-Y","volume":"125","author":"MR Starling","year":"1993","unstructured":"Starling MR. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J. 1993;125:1659\u201366.","journal-title":"Am Heart J"},{"key":"1196_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hfc.2007.10.001","volume":"4","author":"BA Borlaug","year":"2008","unstructured":"Borlaug BA, Kass DA. Ventricular-vascular interaction in heart failure. Heart Fail Clin. 2008;4:23\u201336.","journal-title":"Heart Fail Clin"},{"key":"1196_CR16","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","volume":"128","author":"JM Griffin","year":"2021","unstructured":"Griffin JM, Rosenblum H, Maurer MS. Pathophysiology and therapeutic approaches to cardiac amyloidosis. Circ Res. 2021;128:1554\u201375.","journal-title":"Circ Res"},{"key":"1196_CR17","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1113\/JP271827","volume":"594","author":"D Li","year":"2016","unstructured":"Li D, Paterson DJ. Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness. J Physiol. 2016;594:3993\u20134008.","journal-title":"J Physiol"},{"key":"1196_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaccao.2020.05.012","volume":"2","author":"K Lee Chuy","year":"2020","unstructured":"Lee Chuy K, Drill E, Yang JC, Landau H, Hassoun H, Nahhas O, et al. Incremental value of global longitudinal strain for predicting survival in patients with advanced AL amyloidosis. JACC CardioOncol. 2020;2:223\u201331.","journal-title":"JACC CardioOncol"},{"key":"1196_CR19","doi-asserted-by":"publisher","first-page":"904878","DOI":"10.3389\/fcvm.2022.904878","volume":"9","author":"M Bak","year":"2022","unstructured":"Bak M, Kim D, Choi JO, Kim K, Kim SJ, Jeon ES. Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis. Front Cardiovasc Med. 2022;9:904878.","journal-title":"Front Cardiovasc Med"},{"key":"1196_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oead040","volume":"3","author":"P Geenty","year":"2023","unstructured":"Geenty P, Sivapathan S, Stefani LD, Zada M, Boyd A, Richards D, et al. A novel echocardiographic risk score for light-chain amyloidosis. Eur Heart J Open. 2023;3:oead040.","journal-title":"Eur Heart J Open"},{"key":"1196_CR21","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","volume":"22","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004;22:3751\u20137.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01196-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01196-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01196-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:38:48Z","timestamp":1788943128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01196-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01196-9","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. EK has received honoraria from Janssen, Pfizer, GSK and research support (EK\u2019s institution) from Janssen, GSK and Pfizer. The other authors have no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Institutional Review Board of the participating institution, and all procedures involving human participants were performed in accordance with relevant guidelines and regulations. All participants signed informed consent form. All patient data were anonymized prior to analysis to ensure confidentiality.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}